Dexter Hadley, MD/PhD

Founder, CANONIC Foundation — GOV AI (patent pending) | Director of AI, American Board of Precision Medicine | PI, HadleyLab | From Bits to Bedside ™

[Dexter Hadley, MD/PhD @iDrDex]

6/ Full episode (32 min): https://t.co/0Lsi07nOhH

Build the system you wish existed. Then submit to it.

[Dexter Hadley, MD/PhD @iDrDex]

1/ Back with Glenn Cook on the Global Life Podcast — second time around. Last October I told him we were building "a way that is transparent that is open just like Bitcoin and the blockchain" for patient data. Seven months later, here's what shipped.

[Dexter Hadley, MD/PhD @iDrDex]

5/ CaribChat — 15-nation Caribbean cancer-care federation, OECS deployment in motion. SALUTEM — health tourism, Aruba pilot underway. Same compiler. Different domains.

[Dexter Hadley, MD/PhD @iDrDex]

Pressure-test: does the concentration diagnosis hold without subsidiarity-as-architecture being the cure? Strongest objection to the GEI construct?

Read it: https://t.co/oh5cbfh7VY

https://t.co/u45PMesOm3

[Dexter Hadley, MD/PhD @iDrDex]

Pope Leo XIV's first encyclical, released yesterday, calls AI concentration a "new face of colonialism" that appropriates data without returning value.

It was presented alongside Anthropic's co-founder.

We have the architecture. We also have the data.

https://t.co/oh5cbfh7VY

[Dexter Hadley, MD/PhD @iDrDex]

CANONIC's COIN ledger mints on governed work, supply-ceiling bounded per scope per epoch. Community knowledge stays in the community's governed tree. We do not own it. We cannot extract it.

The anticolonialist architecture isn't a preference. It's a computable economic choice.

[Dexter Hadley, MD/PhD @iDrDex]

Data, scripts, and all figures are in the governed repo. Methodological critique, missing citations, and sponsor-naming pushback all welcome — reply or DM. Read it:

https://t.co/u45PMesOm3

[Dexter Hadley, MD/PhD @iDrDex]

New preprint. The finding is counterintuitive: precision medicine doesn't fail at the reference panel. It fails one step earlier — at the clinical trial. Database sparsity is downstream of enrollment sparsity.

https://t.co/u45PMesOm3

[Dexter Hadley, MD/PhD @iDrDex]

Frame: this is a discovery opportunity, not an equity plea. The empty matrix cells are populations whose drug response is unmeasured — unclaimed scientific ground, not just a fairness gap. Push back on that framing if you disagree.